Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
MUMBAI, June 24 (Reuters) - India's health ministry has formed a committee that will meet for the first time on Tuesday to consider raising the number of drugs deemed essential and subject to price caps, people directly involved in the process said. The committee will consider adding more d
Read more
News that Shire has rejected a £27bn approach by AbbVie sent shares in the pharmaceutical and healthcare equipment sectors higher on Friday as yet more M&A continued to give sentiment a boost. "A bit of M&A excitement has been just the ticket to enliven trading on what may otherwise have been somet
Read more- FTSE 100 at one-week high - Shire jumps after rejecting £27bn AbbVie proposal - TSB rises strongly after IPO - Iran still in the spotlight as Obama sends advisers techMARK 2,849.46 +1.26% FTSE 100 6,827.82 +0.29% FTSE 250 15,761.52 +0.49% UK stocks were making gains on Friday as yet more M&A fev
Read more
LONDON (Alliance News) - WPP PLC said Thursday its operating company XM Asia has acquired a majority stake in Vietnamese digital creative agency Sofresh Co Ltd. Sofresh has a range of clients including Diageo PLC, GlaxoSmithKline PLC and Unilever PLC. It had revenues of VND35.7 billion in 2
Read moreLONDON, June 19 (Reuters) - Drugmakers are linking with eight British universities in a 16 million-pound ($27 million) public-private partnership to speed up research into dementia by studying data from 2 million people in the world's largest such project. The new UK Dementias Research Plat
Read moreAllocate Software: N+1 Singer upgrades to buy with a target price of 133p. Croda International: Numis cuts target price from 2575p to 2554p and maintains its hold recommendation. Diamondcorp: Northland Capital shifts target price from 9.9p to 11p and keeps a buy recommendation. Fenner: Credit Su
Read more* CEO says Convergence could raise 50-100 million pounds * Follows success for pain drug in mid-stage trial * UK biotech sector boosted by Circassia IPO in March * Biotech support firm Abzena also announces plan to float By Ben Hirschler LONDON, June 16 (Reuters) - C
Read moreLONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BARCLAYS RAISES RSA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 538 (102) PENCE
----------
SOCGEN CUTS ROLLS-ROYCE TO '
LONDON (Alliance News) - A spin-off company of GlaxoSmithKline PLC is considering a possible stock-market flotation after strong results for its new painkiller, the Financial Times reported Sunday. Convergence Pharmaceuticals was spun off in 2010 when Glaxo restructured its research and dev
Read moreLONDON (Alliance News) - UK residential and commercial property companies are among the biggest fallers in a declining market Friday, after Bank of England Governor Mark Carney said the interest rates in the UK could rise sooner than investors expect and Chancellor of the Exchequer George Osbo
Read moreLONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Petra Diamonds Ltd shares jumped to the top of the FTSE 250 index after saying it has recovered another exceptional 122.52 carat
LONDON (Alliance News) - The deteriorating situation in Iraq has depressed shares early Friday, as the UK market also contemplates a sooner-than-expected rise in interest rates by the Bank of England.
SSE, Tullow Oil and BG Group le
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday a late stage study of its drug eltrombopag for the treatment of chronic immune thrombocytopenia in paediatric patients had met its primary endpoint. Immune thrombocytopenia is a bleeding disorder where the blood does not clot properly
Read more* Charges against GSK's Mark Reilly shocked business community * Managers weigh legal responsibility of taking top positions * Crackdown is part of wider campaign against corruption By Adam Jourdan SHANGHAI, June 13 (Reuters) - China's crackdown on corruption in the pharma
Read moreLONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon:
----------
FTSE 100
----------
NOMURA CUTS BG GROUP TO 'NEUTRAL' ('BUY') - PRICE TARGET 1350 PENCE
----------
TRADERS: INVE
Last checked at